Cyanin Chloride Inhibits Hyperbaric Pressure-Induced Decrease of Intracellular Glutamate-Aspartate Transporter in Rat...

Area of Science:

• Ophthalmology
• Neuroscience
• Cell Biology

Background:

• Glaucoma is a leading cause of irreversible blindness globally.
• Elevated glutamate levels and impaired glutamate transport contribute to optic nerve damage in glaucoma.
• Retinal Müller cells play a role in glaucoma pathogenesis via the glutamate-aspartate transporter (GLAST).

Purpose of the Study:

• To investigate the neuroprotective effects of cyanin chloride, an anthocyanin, on rat retinal Müller cells.
• To determine if cyanin chloride can inhibit hyperbaric pressure-induced decreases in GLAST expression.
• To evaluate cyanin chloride as a potential therapeutic agent for glaucoma.

Main Methods:

• Cultured rat Müller cells were subjected to hyperbaric pressure (60 mmHg).
• Cells were treated with varying concentrations of cyanin chloride or a vehicle control.
• Cell survival was assessed using MTT assay; GLAST mRNA and protein levels were quantified via RT-PCR and Western blot.

Main Results:

• Hyperbaric pressure significantly reduced cell survival and GLAST expression in Müller cells.
• Cyanin chloride treatment significantly improved cell survival under hyperbaric conditions.
• Cyanin chloride effectively inhibited the hyperbaric pressure-induced reduction in GLAST mRNA and protein expression.

Conclusions:

• Cyanin chloride demonstrates significant neuroprotective effects on rat retinal Müller cells against hyperbaric pressure.
• The findings support the hypothesis that cyanin chloride can prevent hyperbaric pressure-induced GLAST reduction.
• Cyanin chloride shows promise as a novel therapeutic strategy for glaucoma management.